Artiva Biotherapeutics, Inc. (ARTV) ROA
- 2026-06-30: ROA -24.64%.
- 2026-03-31: ROA -82.18%.
- 2025-12-31: ROA -64.05%.
- 2025-09-30: ROA -53.20%.
Complete source-backed roa history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|---|
| 2026-06-30 | -24.64% |
| 2026-03-31 | -82.18% |
| 2025-12-31 | -64.05% |
| 2025-09-30 | -53.20% |
| 2025-06-30 | -44.35% |
| 2025-03-31 | -37.50% |
| 2024-12-31 | -31.19% |
| 2024-09-30 | -27.16% |
| 2024-06-30 | -42.85% |
| 2023-12-31 | -27.32% |
Annual ROA
| Date | ROA |
|---|---|
| 2025-12-31 | -64.05% |
| 2024-12-31 | -31.19% |
| 2023-12-31 | -27.32% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |